These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1743470)

  • 1. [Pregnancy with an extremely rare P blood group with anti-PP1Pk].
    Strowitzki T; Wiedemann R; Heim MU; Brehm G; Roithmeier A
    Geburtshilfe Frauenheilkd; 1991 Sep; 51(9):710-3. PubMed ID: 1743470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasmapheresis and/or intermediate high dosage immunoglobulin therapy--effective measures in threatened premature labor and intrauterine hemolysis in anti-PP1Pk (-Tja)?].
    Heim MU; Weidemann R; Brehm G; Versmold H; Mempel W
    Beitr Infusionsther; 1990; 26():302-6. PubMed ID: 1703859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmapheresis for the treatment of repeated early pregnancy wastage associated with anti-P.
    Rock JA; Shirey RS; Braine HG; Ness PM; Kickler TS; Niebyl JR
    Obstet Gynecol; 1985 Sep; 66(3 Suppl):57S-60S. PubMed ID: 4022518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemolyzing antibodies to markers of the P blood factor system as a problem in blood transfusion and pregnancy. With reference to serology, biochemistry and genetics].
    Pausch V; Speiser P; Michl U; Höcker P; Engelfriet CP
    Wien Klin Wochenschr; 1990 Feb; 102(3):80-90. PubMed ID: 2316222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with plasmapheresis and intravenous immunoglobulin in pregnancies complicated with anti-PP1Pk or anti-K immunization: a report of two patients.
    Fernández-Jiménez MC; Jiménez-Marco MT; Hernández D; González A; Omeñaca F; de la Cámara C
    Vox Sang; 2001 Feb; 80(2):117-20. PubMed ID: 11348543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment by double filtrate plasmapheresis in a pregnant woman with the rare P blood group and a history of multiple early miscarriages.
    Hanafusa N; Noiri E; Yamashita T; Kondo Y; Suzuki M; Watanabe Y; Kanai T; Miyashita E; Tsuno NH; Fujii T; Kozuma S; Takahashi K; Taketani Y; Nakao A; Fujita T
    Ther Apher Dial; 2006 Dec; 10(6):498-503. PubMed ID: 17199881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Incidence of materno-fetal isoimmunization against the Rh factor (D)].
    Marmorino C
    Minerva Med; 1972 Dec; 63(86):4699-707. PubMed ID: 4629911
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment with plasma exchange of a pregnant woman with anti-PP1Pk alloimmunization: A case report.
    Pignalosa O; Vigorita E; Capuano M; Caruso S; Mastroianni A; De Martino S; Vaccaro G; Meomartini D; Nocera C
    Transfus Apher Sci; 2024 Apr; 63(2):103871. PubMed ID: 38245405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-Tja (PP1Pk) isoimmunization. A case, a review of the literature].
    Haentjens-Verbeke K; Dufour P; Vinatier D; Bernardi C; Fonteyne G; Monnier JC; Mannessier L
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(4):393-7. PubMed ID: 8360439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidisciplinary management of anti-PP1P
    Lépine MS; Goua V; Debouverie OS; Giraud C; Rafat C; Thonier V; Masmouhi BE; Ndour CT; Huguet-Jacquot S; Mailloux A; Cortey A; Jouannic JM; Maisonneuve E
    Transfusion; 2021 Jun; 61(6):1972-1979. PubMed ID: 33811650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Severe fetomaternal anti-Duffy allo-immunization].
    Dufour P; Vinatier D; Bernardi C; Ezzedine M; Fonteyne G; Monnier JC; Mannessier L
    J Gynecol Obstet Biol Reprod (Paris); 1991; 20(6):809-14. PubMed ID: 1822490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 13. [Blood group incompatibility in childhood].
    Felsenreich G; Rosenkranz A
    Wien Med Wochenschr; 1970 May; 120(22):397-400. PubMed ID: 4996901
    [No Abstract]   [Full Text] [Related]  

  • 14. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On the action of anti-D immunoglobulin in the Rh-positive organism. Review of hitherto observed faulty use of anti-D immunoglobulin].
    Niederhoff H; Schneider J; Stachow P; Künzer W
    Dtsch Med Wochenschr; 1969 Jul; 94(28):1437-40. PubMed ID: 4182164
    [No Abstract]   [Full Text] [Related]  

  • 16. [Spectrophotometric analysis of amniotic fluid prenatal diagnosis of fetal erythroblastosis].
    Radzuweit H; Eckert L; Zachäus V; Weigel W
    Zentralbl Gynakol; 1971 Mar; 93(12):380-7. PubMed ID: 4995302
    [No Abstract]   [Full Text] [Related]  

  • 17. Haemolytic disease of the newborn due to Rh-isoimmunization: the role of free anti-D antibodies in bilirubin rebound.
    Pataki L
    Acta Paediatr Acad Sci Hung; 1970; 11(3):219-29. PubMed ID: 5004392
    [No Abstract]   [Full Text] [Related]  

  • 18. Positive cord blood "DAT" due to anti-Le(a): absence of hemolytic disease of the newborn.
    Abhyankar S; Silfen S; Rao SP; Vinciguerra C; Dimiaio TM
    Am J Pediatr Hematol Oncol; 1989; 11(2):184-5. PubMed ID: 2787608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemolytic disease of the newborn and anti-E and anti-c immunization].
    Hervei S; Filonyenko A; Kiszel J; Drexler M
    Orv Hetil; 1972 Dec; 113(49):2965-6. PubMed ID: 4655762
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical and laboratory contribution to the prevention of fetal hemoblastosis].
    Carbonini M; Follini G
    Ann Ostet Ginecol Med Perinat; 1972 Aug; 93(8):579-84. PubMed ID: 4202141
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.